Impacts of Bacillus subtilis JQ61816 on lipid panel and expression of genes involved in cholesterol metabolism in hypercholesterolemic rats

Journal of Current Biomedical Reports

View Publication Info
 
 
Field Value
 
Title Impacts of Bacillus subtilis JQ61816 on lipid panel and expression of genes involved in cholesterol metabolism in hypercholesterolemic rats
 
Creator Dehkohneh, Abolfazl
Khalili, Azam
Ardalani, Omid
Mohsenzadeh, Amin
Sabati, Hoda
Jafari, Parvaneh
 
Subject Biotechnology; Biochemistry
Probiotics; Bacillus subtilis; Hypercholesterolemia; Cardiovascular disease; Triglyceride
 
Description Hypercholesterolemia is one of the major risk factors associated with the emergence and development of cardiovascular diseases (CVD) and atherosclerosis. The hypocholesterolemic effects of probiotics have been indicated by numerous studies. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and cytochrome P450 7A1 or cholesterol 7 alpha-hydroxylase (CYP7A1) are two important genes in choletsterol metabolism. In this study, the effects of Bacillus subtilis JQ61816 on lipid panel, hepatic enzymes and expression levels of HMGCR and CYP7A1 were investigated. Twenty-one male Wistar rats were randomly allotted to 3 experimental groups; a) negative control group (ND) fed with normal diet, b) high-fat diet group (HFD) fed with high cholesterol diet, and c) probiotic group (BS) fed with high cholesterol diet supplemented with probiotic B. subtilis. Serum analysis of treatment groups was performed to measure fasting blood sugar (FBS), lipid profile parameters, hepatic enzymes, urea, and uric acid. Our results showed that B. subtilis could reduce the level of total cholesterol, triglycerides, and LDL and it also could increase high-density lipoprotein (HDL) level. Moreover, alanine transaminase (ALT), aspartate transaminase (AST), and uric acid were significantly lower in BS group compare to HFD group. Furthermore, up-regulation of HMGCR and down-regulation of CYP7A1 were observed in BS group. The results of our study suggest that consumption of probiotic B. subtilis JQ61816 may prevent or decline the development of hypercholesterolemia and other cardiovascular diseases.
 
Publisher ParsPublisher
 
Contributor
 
Date 2021-12-30
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
 
Identifier https://jcbior.com/index.php/JCBioR/article/view/108
10.52547/JCBioR.2.4.176
 
Source Journal of Current Biomedical Reports; VOL 2, NO 4 (2021). OCT-DEC; 176-184
2717-1906
 
Language eng
 
Relation https://jcbior.com/index.php/JCBioR/article/view/108/PDF
https://jcbior.com/index.php/JCBioR/article/view/108/Docx
https://jcbior.com/index.php/JCBioR/article/view/108/Fa
 
Rights Copyright (c) 2021 © The Author(s)
https://creativecommons.org/licenses/by-nc/4.0
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library